← All trials
NCT06493552
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2024
- Primary completion
- Sep 30, 2029
- Completion date
- Aug 31, 2034
- First posted
- Jul 10, 2024
- Last posted
- Sep 19, 2024
- Enrollment
- 700
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Vasgene Therapeutics, IncLead sponsor
- University of Southern CaliforniaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.